Bioniche Life Sciences, Inc. will reorganize its corporate leadership team in an effort to increase efficiency and better position the company for strategic growth. In the Human Health business unit, Dr. François Charette, senior vice president of Medical Affairs and chief medical officer, has left the company. Monique Champagne, vice president, Clinical Research, will assume leadership and will be working with the Human Health team to identify and pursue new human health indications for the company’s Mycobacterial Cell Wall-DNA Complex (MCC) technology. Ms. Champagne joined the company as director of Clinical Research in 2006.

In the Bioniche Animal Health business unit, Jim Phillips, president of Bioniche Animal Health, will now serve as senior vice president of industry relations. This is a strategic position to pursue potential product and technology acquisitions, as well as to be more engaged with the veterinarian community. Mr. Phillips has been with the company for 25 years and has provided strong leadership to the Animal Health division.

Andrew Grant, divisional president of Bioniche Animal Health Export Sales, Europe and Asia, has been promoted to president of Bioniche Animal Health. Mr. Grant has been with the company for 12 years and has a broad depth of knowledge of the industry and an excellent awareness of potential future growth opportunities for the business.

“Having successfully concluded an equity financing in December, the company is poised with the financial resources it requires to more efficiently advance a number of its key strategic projects,” said Graeme McRae, chairman, president and chief executive officer of Bioniche Life Sciences. “At the same time, we must ensure that we have the appropriate people in key leadership positions to take advantage of the opportunities in front of us. I believe that the administrative reorganization achieves this objective.”